Quest Diagnostics: Good Q1, Solid Business, Steady Share Price Upside Likely [Seeking Alpha]
Quest Diagnostics Incorporated (DGX)
Last quest diagnostics incorporated earnings: 4/22 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
ir.questdiagnostics.com
Company Research
Source: Seeking Alpha
DGX maintains a strong core business with high barriers to entry, steady but unspectacular growth, and industry-leading market access. Forward P/E is ~19x and P/S $5.2 billion) and interest expense, though management is unconcerned. I reiterate a "Buy" rating, expecting steady long-term upside driven by demographic tailwinds, improving reimbursement, and disciplined capital returns. Looking for a portfolio of ideas like this one? Members of Haggerston BioHealth get exclusive access to our subscriber-only portfolios. Learn More » Richard Drury/DigitalVision via Getty Images Investment Overview Quest Diagnostics ( DGX announced its Q1 2026 earnings earlier this week. Before we take a detailed look at the numbers, let's remind ourselves of the New Jersey-based Life Sciences core business activities - as per its Q1 2026 quarterly report/ More on my IG service If you are interested in keeping up to date with stocks making moves within the biotech, pharma and healthcare ind
Show less
Read more
Impact Snapshot
Event Time:
DGX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DGX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DGX alerts
High impacting Quest Diagnostics Incorporated news events
Weekly update
A roundup of the hottest topics
DGX
News
- Orkes Raises $60M as Developers Increasingly Use Its Platform to Deploy AI Confidently in Production [Yahoo! Finance]Yahoo! Finance
- Quest Diagnostics (DGX) had its price target raised by UBS Group AG from $210.00 to $220.00. They now have a "neutral" rating on the stock.MarketBeat
- Quest Diagnostics deal helps push Secaucus office tower past 75% occupancy [Yahoo! Finance]Yahoo! Finance
- Quest Diagnostics (DGX) had its price target raised by Robert W. Baird from $224.00 to $229.00. They now have a "neutral" rating on the stock.MarketBeat
- Quest Diagnostics (DGX) had its price target raised by Barclays PLC from $225.00 to $230.00. They now have an "overweight" rating on the stock.MarketBeat
DGX
Earnings
- 4/21/26 - Beat
DGX
Sec Filings
- 4/24/26 - Form 4
- 4/24/26 - Form 4
- 4/24/26 - Form 4
- DGX's page on the SEC website